Coldaid
- Manufacturer
- PRINCE OF PEACE ENTERPRISES INC.
- Effective date
- 2014-04-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-05-31 22:39:06
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients Purpose
Menthol 245 mg...........................Oral Pain Reliever
OTC - PURPOSE SECTION
Uses For the temporary relief of sore throat
OTC - WHEN USING SECTION
When using this product
- Do not exceed recommended dosage
OTC - ASK DOCTOR/PHARMACIST SECTION
Stop use and ask a doctor if
- sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting
- sore mouth symptoms do not improve in 7 days
- irritation, pain, or redness persists or worsens
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep this and all drugs out of reach of children.
OTC - QUESTIONS SECTION
- Questions? 1-510-887-1899 Monday to Friday, 8 am - 5 pm Pacific Standard Time
DOSAGE & ADMINISTRATION SECTION
Directions
| Adults and children 12 years of age and older | Place 2 bags in 6 oz of boiling water and stir. Allow liquid to cool. Drink up to 4 times daily or as directed by a doctor. |
| Children under 12 years of age | Ask a doctor |
WARNINGS SECTION
In the case of accidental overdose, seek professional assistance or contact a poison control center immediately.
Do not use otherwise than as directed.
INDICATIONS & USAGE SECTION
Uses For the temporary relief of sore throat.
INACTIVE INGREDIENT SECTION
Japanese Hondysuckle Flower, Forsythia Fruit, Platycodon Root, Burdock Fruit, Licorice Root, Soybean, Schizonepeta Stem, Lophatherum Stem and Leaves, Lactose
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62003-001-25 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3783-60a7-e053-dbdaa90a05bd | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62003-001-25 | Coldaid | 2.5 g in 1 PACKET | GRANULE, FOR SOLUTION | 2.5 | 4 | |
| 62003-001-25 | Coldaid | 10 in 1 BOX | GRANULE, FOR SOLUTION | 10 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Menthol | ACTIVE INGREDIENT | L7T10EIP3A | 4 | |
| Menthol | ACTIVE MOIETY | L7T10EIP3A | 4 | |
| ARCTIUM LAPPA FRUIT | INACTIVE INGREDIENT | EA541308MV | 4 | |
| FORSYTHIA SUSPENSA FRUIT | INACTIVE INGREDIENT | P4793M1ES5 | 4 | |
| GLYCYRRHIZA GLABRA | INACTIVE INGREDIENT | 2788Z9758H | 4 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 4 | |
| LONICERA CAPRIFOLIUM FLOWER | INACTIVE INGREDIENT | 5N1WD9784U | 4 | |
| LOPHATHERUM GRACILE LEAF | INACTIVE INGREDIENT | R417138GE9 | 4 | |
| PLATYCODON GRANDIFLORUM LEAF | INACTIVE INGREDIENT | 2L64H2X8DY | 4 | |
| SCHIZONEPETA TENUFOLIA SPIKE | INACTIVE INGREDIENT | 2FN3BA1MZE | 4 | |
| SOYBEAN | INACTIVE INGREDIENT | L7HT8F1ZOD | 4 |
Products#
Every source-derived product name is available through these pages.
- Coldaid
- menthol
- LONICERA CAPRIFOLIUM FLOWER
- FORSYTHIA SUSPENSA FRUIT
- PLATYCODON GRANDIFLORUM LEAF
- ARCTIUM LAPPA FRUIT
- GLYCYRRHIZA GLABRA
- SOYBEAN
- SCHIZONEPETA TENUFOLIA SPIKE
- LOPHATHERUM GRACILE LEAF
- LACTOSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62003-001 | 62003-001-25 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Menthol | L7T10EIP3A | ACTIB |
| LONICERA CAPRIFOLIUM FLOWER | 5N1WD9784U | IACT |
| FORSYTHIA SUSPENSA FRUIT | P4793M1ES5 | IACT |
| PLATYCODON GRANDIFLORUM LEAF | 2L64H2X8DY | IACT |
| ARCTIUM LAPPA FRUIT | EA541308MV | IACT |
| GLYCYRRHIZA GLABRA | 2788Z9758H | IACT |
| SOYBEAN | L7HT8F1ZOD | IACT |
| SCHIZONEPETA TENUFOLIA SPIKE | 2FN3BA1MZE | IACT |
| LOPHATHERUM GRACILE LEAF | R417138GE9 | IACT |
| LACTOSE | J2B2A4N98G | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 133 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / RESPIRATORY (INHALATION) | 44.4 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| SOYBEAN | SOYBEAN | L7HT8F1ZOD | CAPSULE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / RECTAL | 20 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, SOLUTION / INTRAVENOUS | 0.45 %w/v | ||
| LACTOSE | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | FILM, EXTENDED RELEASE / TRANSDERMAL | 675 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / VAGINAL | 430 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| SOYBEAN | SOYBEAN | L7HT8F1ZOD | EMULSION / TOPICAL | 3 %w/w | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 133 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / BUCCAL | 296.7 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / RECTAL | 8 %w/v | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CREAM / VAGINAL | 3 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0935f36f-52db-42ec-ba9d-d98874cff723 | 0e6c5a84-4ca4-40a4-b8d6-253aeeea479b | 2014-04-01 | Warnings | 0935f36f-52db-42ec-ba9d-d98874cff723 0e6c5a84-4ca4-40a4-b8d6-253aeeea479b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
